The disruption of critical genes is a hallmark of cancer. Identification of these genes is a first step to understanding the disease, but once the genes have been identified, elucidating changes in their expression levels can aid in identifying biomarkers with the potential to predict disease progression and point to appropriate treatments. Approaches to determine the relevance of prospective gene expression signatures for the identification of important disease phenotypes will be discussed. Our webinar panelists, both cancer experts, will describe their research and how they have translated their own discoveries into validated gene expression signatures using arrays.
During the webinar, the speakers will:
• Describe their experimental approaches to validating genetic signatures
• Share their findings demonstrating the potential correlation of gene expression biomarkers with known cancer phenotypes
• Address the most critical factors when considering validating gene expression data
• Answer your questions live on air!
For more information on products/technologies related to this webinar, go to: www.affymetrix.com/genomics